TFF Pharmaceuticals Q3 EPS $(0.09) Beats $(0.11) Estimate, Sales $234.76K Beat $50.00K Estimate
Author: Benzinga Newsdesk | November 14, 2023 05:52pm
TFF Pharmaceuticals (NASDAQ:
TFFP) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 68.97 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $234.76 thousand which beat the analyst consensus estimate of $50.00 thousand by 369.53 percent. This is a 168.04 percent increase over sales of $87.59 thousand the same period last year.
Posted In: TFFP